BioAtla (BCAB) Capital Expenditures (2020 - 2023)
BioAtla (BCAB) posted quarterly Capital Expenditures of $8000.0 for Q4 2023, down 97.0% year-over-year from $267000.0 in Q4 2022, and down 68.0% quarter-over-quarter from $25000.0 in Q3 2023.
BioAtla (BCAB) Capital Expenditures (2020 - 2023) Analysis & Trends
BioAtla's Capital Expenditures history runs 4 years deep, the most recent figure standing at $8000.0 for Q4 2023.
- In Q4 2023, Capital Expenditures fell 97.0% year-over-year to $8000.0; the TTM figure through Sep 2024 stood at $8000.0 (down 97.76% YoY), while the FY2023 annual figure was $98000.0, down 63.43% from the prior year.
- Capital Expenditures for Q4 2023 stood at $8000.0, down from $25000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $793000.0 in Q3 2021, with the low at -$834000.0 in Q4 2021.
- The 4-year median for Capital Expenditures is $24000.0 (2022), against an average of $59812.5.
- Peak annual rise in Capital Expenditures reached 627.52% in 2021, while the deepest fall reached 565.22% in 2021.
- BioAtla's Capital Expenditures stood at $395000.0 in 2020, then slumped by 311.14% to -$834000.0 in 2021, then surged by 132.01% to $267000.0 in 2022, then slumped by 97.0% to $8000.0 in 2023.
- Business Quant data shows BCAB's Capital Expenditures at $8000.0 in Q4 2023, $25000.0 in Q3 2023, and $15000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 34.68 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.26 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 251.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -73.57 Mn |
| 10 | BioAtla | 5.28 Mn | 5.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 8,000.00 |
| Dec 31, 2023 | 8,000.00 |
| Sep 30, 2023 | 25,000.00 |
| Sep 30, 2023 | 25,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | 267,000.00 |
| Dec 31, 2022 | 267,000.00 |
| Sep 30, 2022 | -32,000.00 |
| Sep 30, 2022 | -32,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Mar 31, 2022 | 23,000.00 |
| Mar 31, 2022 | 23,000.00 |
| Dec 31, 2021 | -834,000.00 |
| Dec 31, 2021 | -834,000.00 |
| Sep 30, 2021 | 793,000.00 |
| Sep 30, 2021 | 793,000.00 |